Investors eyeing a purchase of Seres Therapeutics Inc (MCRB) stock, but cautious about paying the going market price of $10.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2018 put at the $7.50 strike, which has a bid at the time of this writing of 55 cents..